{"altmetric_id":16456680,"counts":{"readers":{"mendeley":21,"citeulike":0,"connotea":0},"total":{"posts_count":4},"wikipedia":{"unique_users_count":4,"unique_users":["en:5080673","en:13278230","en:5076150","en:443854"],"posts_count":4}},"citation":{"altmetric_jid":"4f6fa4e93cf058f61000244e","authors":["Scheffer, PG","van der Schoot, CE","Page\u2010Christiaens, GCML","de Haas, M"],"doi":"10.1111\/j.1471-0528.2011.03028.x","first_seen_on":"2017-02-16T05:05:11+00:00","issns":["14700328","1471-0528"],"journal":"British Journal of Obstetrics & Gynaecology","last_mentioned_on":1488818063,"links":["http:\/\/dx.doi.org\/10.1111\/j.1471-0528.2011.03028.x"],"pdf_url":"http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2011.03028.x\/pdf","pmid":"21668766","pubdate":"2011-06-14T00:00:00+00:00","publisher":"Blackwell Publishing Ltd","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["obstetrics","gynecology"],"title":"Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience","type":"article","uri":"http:\/\/doi.wiley.com\/10.1111\/j.1471-0528.2011.03028.x","mendeley_url":"http:\/\/www.mendeley.com\/research\/noninvasive-fetal-blood-group-genotyping-rhesus-d-c-e-k-alloimmunised-pregnant-women-evaluation-7yea"},"altmetric_score":{"score":3,"score_history":{"1y":3,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":8317445,"mean":7.0084957256017,"rank":2126726,"this_scored_higher_than_pct":60,"this_scored_higher_than":5056090,"rank_type":"exact","sample_size":8317445,"percentile":60},"similar_age_3m":{"total_number_of_other_articles":242458,"mean":13.674376058435,"rank":86708,"this_scored_higher_than_pct":62,"this_scored_higher_than":151635,"rank_type":"exact","sample_size":242458,"percentile":62},"this_journal":{"total_number_of_other_articles":3486,"mean":7.8734898134864,"rank":1487,"this_scored_higher_than_pct":31,"this_scored_higher_than":1088,"rank_type":"exact","sample_size":3486,"percentile":31},"similar_age_this_journal_3m":{"total_number_of_other_articles":109,"mean":11.95162962963,"rank":81,"this_scored_higher_than_pct":25,"this_scored_higher_than":28,"rank_type":"exact","sample_size":109,"percentile":25}}},"demographics":{"users":{"mendeley":{"by_status":{"Librarian":2,"Researcher":6,"Student  > Doctoral Student":1,"Student  > Postgraduate":2,"Student  > Master":3,"Student  > Bachelor":2,"Lecturer":1,"Lecturer > Senior Lecturer":2,"Professor":2},"by_discipline":{"Medicine and Dentistry":10,"Social Sciences":2,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":6,"Nursing and Health Professions":1,"Biochemistry, Genetics and Molecular Biology":1}}},"geo":{"mendeley":{"US":1,"ES":1}}},"posts":{"wikipedia":[{"title":"Hemolytic disease of the newborn (anti-Rhc)","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=767415691#altmetric_citation_08c5fba6-b415-4e27-bc15-72d80cad0fac","license":"public","citation_ids":[16456680],"posted_on":"2017-02-25T20:11:46+00:00","summary":"Hemolytic disease of the newborn (anti-Rhc) can range from a mild to a severe disease.","page_url":"http:\/\/en.wikipedia.org\/?curid=5080673","wiki_lang":"en","author":{"name":"Chris Capoccia","url":"http:\/\/en.wikipedia.org\/wiki\/User:Chris Capoccia"}},{"title":"Hemolytic disease of the newborn (anti-RhE)","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=765732216#altmetric_citation_006cf9e2-2719-465a-9fe7-cc5399a5f8b1","license":"public","citation_ids":[16456680],"posted_on":"2017-02-16T03:23:36+00:00","summary":"Hemolytic disease of the newborn (anti-RhE) is caused by the anti-RhE antibody of the Rh blood group system.","page_url":"http:\/\/en.wikipedia.org\/?curid=13278230","wiki_lang":"en","author":{"name":"Chris Capoccia","url":"http:\/\/en.wikipedia.org\/wiki\/User:Chris Capoccia"}},{"title":"Hemolytic disease of the newborn (anti-Kell)","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=766337811#altmetric_citation_bf65fd98-7d1a-4477-b6c3-327064882d2c","license":"public","citation_ids":[16456680],"posted_on":"2017-02-19T16:54:56+00:00","summary":"Hemolytic disease of the newborn (anti-Kell1) is the second most common cause of severe hemolytic disease of the newborn (HDN) after Rh disease.","page_url":"http:\/\/en.wikipedia.org\/?curid=5076150","wiki_lang":"en","author":{"name":"Chris Capoccia","url":"http:\/\/en.wikipedia.org\/wiki\/User:Chris Capoccia"}},{"title":"Rh disease","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=768933528#altmetric_citation_9572194e-e84f-4b40-9e9d-3f3baeabe0c3","license":"public","citation_ids":[16456680],"posted_on":"2017-03-06T16:34:23+00:00","summary":"Rh disease (also known as rhesus isoimmunisation, Rh (D) disease, rhesus incompatibility, rhesus disease, RhD hemolytic disease of the newborn, rhesus D hemolytic disease of the newborn or RhD HDN) is a type of hemolytic disease of the newborn (HDN).","page_url":"http:\/\/en.wikipedia.org\/?curid=443854","wiki_lang":"en","author":{"name":"Chris Capoccia","url":"http:\/\/en.wikipedia.org\/wiki\/User:Chris Capoccia"}}]}}